(0350000136) BIOPLEX200 ANALYSIS OF CELLULAR SUPERNATANTS OR HUMAN SERUMS (Q4129303): Difference between revisions
Jump to navigation
Jump to search
(Changed label, description and/or aliases in da, el, hr, ro, sk, mt, pt, fi, pl, sl, cs, lt, lv, bg, hu, ga, sv, et, nl, fr, de, it, es, and other parts: Adding translations: da, el, hr, ro, sk, mt, pt, fi, pl, sl, cs, lt, lv, bg, hu, ga, sv, et,) |
(Changed label, description and/or aliases in pt) |
||||||||||||||
(5 intermediate revisions by 2 users not shown) | |||||||||||||||
label / pt | label / pt | ||||||||||||||
(0350000136) ANÁLISE | (0350000136) BIOPLEX200 ANÁLISE DE SUPERNATIVOS CELULARES OU SÉRUMAS HUMANAS | ||||||||||||||
Property / beneficiary name (string) | |||||||||||||||
Property / beneficiary name (string): PROBIOTICAL RESEARCH SRL / rank | |||||||||||||||
Property / beneficiary | |||||||||||||||
Property / beneficiary: Q4128504 / rank | |||||||||||||||
Property / summary: (0350000136) BIOPLEX200 ANALYSIS OF CELLULAR SUPERNATANTS OR HUMAN SERUMS (English) / qualifier | |||||||||||||||
readability score: 0.0056740800956038
| |||||||||||||||
Property / summary | Property / summary | ||||||||||||||
(0350000136) BIOPLEX200 ANÁLISE DE SUPERNATIVOS CELULARES OU SÉRUMAS HUMANAS (Portuguese) | |||||||||||||||
Property / contained in Local Administrative Unit | |||||||||||||||
Property / contained in Local Administrative Unit: Momo / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / beneficiary | |||||||||||||||
Property / beneficiary: PROBIOTICAL RESEARCH SRL / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / beneficiary name (string) | |||||||||||||||
PROBIOTICAL RESEARCH SRL | |||||||||||||||
Property / beneficiary name (string): PROBIOTICAL RESEARCH SRL / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / priority axis | |||||||||||||||
Property / priority axis: “RESEARCH, TECHNOLOGICAL DEVELOPMENT AND INNOVATION” / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / thematic objective | |||||||||||||||
Property / thematic objective: Research and innovation / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / start time | |||||||||||||||
8 April 2021
| |||||||||||||||
Property / start time: 8 April 2021 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / end time | |||||||||||||||
31 December 2021
| |||||||||||||||
Property / end time: 31 December 2021 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / date of last update | |||||||||||||||
8 April 2023
| |||||||||||||||
Property / date of last update: 8 April 2023 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / Call for proposal | |||||||||||||||
Property / Call for proposal: 14-20 V IR  Voucher alle imprese per l acquisizione di servizi qualificati e specialistici per la ricerca e innovazione presso Infrastrutture di Ricerca pubbliche e private (IR) / rank | |||||||||||||||
Normal rank |
Latest revision as of 14:36, 11 October 2024
Project Q4129303 in Italy
Language | Label | Description | Also known as |
---|---|---|---|
English | (0350000136) BIOPLEX200 ANALYSIS OF CELLULAR SUPERNATANTS OR HUMAN SERUMS |
Project Q4129303 in Italy |
Statements
11,760.0 Euro
0 references
23,520.0 Euro
0 references
50.0 percent
0 references
8 April 2021
0 references
31 December 2021
0 references
PROBIOTICAL RESEARCH SRL
0 references
(0350000136) ANALISI TRAMITE PIATTAFORMA BIOPLEX200 DI SUPERNATANTI CELLULARI O SIERI UMANI (Italian)
0 references
(0350000136) ANÁLISIS BIOPLEX200 DE SOBRENADANTES CELULARES O SUEROS HUMANOS (Spanish)
30 January 2022
0 references
(0350000136) BIOPLEX200 ANALYSIS OF CELLULAR SUPERNATANTS OR HUMAN SERUMS (English)
31 January 2022
0.0056740800956038
0 references
(0350000136) ANALYSE BIOPLEX200 DE SURNAGEANTS CELLULAIRES OU DE SÉRUMS HUMAINS (French)
1 February 2022
0 references
(0350000136) BIOPLEX200 ANALYSE VON ZELLULÄREN ÜBERSTÄNDEN ODER MENSCHLICHEN SEREN (German)
3 February 2022
0 references
(0350000136) BIOPLEX200 ANALYSE VAN CELLULAIRE SUPERNATANTIA OF MENSELIJKE SERUMS (Dutch)
3 February 2022
0 references
(0350000136) BIOPLEX200 ANALYSE AF CELLULÆRE SUPERNATANTER ELLER HUMANE SERUM (Danish)
20 July 2022
0 references
(0350000136) ΑΝΆΛΥΣΗ ΚΥΤΤΑΡΙΚΏΝ ΥΠΕΡΚΕΙΜΈΝΩΝ Ή ΑΝΘΡΏΠΙΝΩΝ ΟΡΏΝ BIOPLEX200 (Greek)
20 July 2022
0 references
(0350000136) BIOPLEX200 ANALIZA STANIČNIH SUPERNATANATA ILI LJUDSKIH SERUMA (Croatian)
20 July 2022
0 references
(0350000136) ANALIZA BIOPLEX200 A SUPERNATANTELOR CELULARE SAU A SERULUI UMAN (Romanian)
20 July 2022
0 references
(0350000136) BIOPLEX200 ANALÝZA BUNKOVÝCH SUPERNATANTOV ALEBO ĽUDSKÝCH SÉR (Slovak)
20 July 2022
0 references
(0350000136) ANALIŻI BIOPLEX200 TA’ SUPERNATANTI ĊELLULARI JEW SERUMS UMANI (Maltese)
20 July 2022
0 references
(0350000136) BIOPLEX200 ANÁLISE DE SUPERNATIVOS CELULARES OU SÉRUMAS HUMANAS (Portuguese)
20 July 2022
0 references
(0350000136) BIOPLEX200 SOLUJEN SUPERNATANTTIEN TAI IHMISEN SEERUMIEN ANALYYSI (Finnish)
20 July 2022
0 references
(0350000136) ANALIZA BIOPLEX200 SUPERNATANTÓW KOMÓRKOWYCH LUB SUROWIC LUDZKICH (Polish)
20 July 2022
0 references
(0350000136) BIOPLEX200 ANALIZA CELIČNIH SUPERNATANTOV ALI ČLOVEŠKIH SERUMOV (Slovenian)
20 July 2022
0 references
(0350000136) BIOPLEX200 ANALÝZA BUNĚČNÝCH SUPERNATANTŮ NEBO LIDSKÝCH SÉR (Czech)
20 July 2022
0 references
(0350000136) BIOPLEX200 LĄSTELIŲ SUPERNATANTŲ ARBA ŽMOGAUS SERUMŲ ANALIZĖ (Lithuanian)
20 July 2022
0 references
(0350000136) BIOPLEX200 ŠŪNU SUPERNATANTU VAI CILVĒKA SERUMU ANALĪZE (Latvian)
20 July 2022
0 references
(0350000136) BIOPLEX200 АНАЛИЗ НА КЛЕТЪЧНИ СУПЕРНАТАНТИ ИЛИ ЧОВЕШКИ СЕРУМИ (Bulgarian)
20 July 2022
0 references
(0350000136) BIOPLEX200 SEJTES SZUPERNATÁNSOK VAGY HUMÁN SZÉRUMOK ELEMZÉSE (Hungarian)
20 July 2022
0 references
(0350000136) ANAILÍS BIOPLEX200 AR SUPERNATANTS CHEALLACHA NÓ SÉRUMAÍ DAONNA (Irish)
20 July 2022
0 references
(0350000136) BIOPLEX200-ANALYS AV CELLULÄRA SUPERNATANTER ELLER HUMANSERUM (Swedish)
20 July 2022
0 references
(0350000136) BIOPLEX200 RAKKUDE SUPERNATANTIDE VÕI INIMESE SEERUMITE ANALÜÜS (Estonian)
20 July 2022
0 references
NOVARA
0 references
8 April 2023
0 references